Research, Charts & Company Announcements
Research Tree provides access to ongoing research coverage, media content and regulatory news on BANK OF MONTREAL. We currently have 0 research reports from 0 professional analysts.
|14Feb17 17:57||MKW||BMO Capital Markets to Host 26th Annual Global Metals & Mining Conference|
|07Feb17 20:28||MKW||MEDIA ADVISORY: BMO Financial Group to Announce its First Quarter 2017 Results|
|17Mar16 17:31||MKW||Media Advisory: BMO Financial Group Chief Risk Officer, Surjit Rajpal, to Speak at the National Bank Financial 2016 Canadian Financial Services Conference|
|03Mar16 22:12||MKW||Bank of Montreal to Redeem $700,000,000 5.10% Series D Medium-Term Notes First Tranche|
|01Mar16 19:00||MKW||MEDIA ADVISORY / CONFERENCE CALL: BMO Capital Markets Analysts to Discuss Mining Outlook|
|29Feb16 12:00||MKW||REPEAT: BMO Capital Markets to Host 25th Annual Global Metals & Mining Conference|
|24Feb16 21:53||MKW||REPEAT: BMO Capital Markets to Host 25th Annual Global Metals & Mining Conference|
Frequency of research reports
Research reports on
BANK OF MONTREAL
BANK OF MONTREAL
Another positive verdict
20 Mar 17
Burford’s results for 2016 produced another outstanding set of figures. Revenue grew by 60% to $163.4m with strong growth in the litigation finance business and an additional boost from a secondary sale in the Petersen case. On an underlying basis net income grew to $114m, a 75% increase despite the investment in growing capacity which increased costs. A combination of ongoing investment and gains and increases on valuation saw the fair value of the litigation assets increase 67% to $559m, underpinned by a growth in invested capital to $394m. With the results statement there was an announcement of a further sale of 9% of the Petersen case at a valuation of 20 times the cost of investment.
N+1 Singer - Morning Song 22-03-2017
22 Mar 17
Carador Income Fund (CIFU LN) Premium rating restored, high levels of refinancing activity | Cello Group (CLL LN) Outlook getting brighter – watch Pulsar | Eckoh (ECK LN) Largest ever US secure payments win | eg solutions (EGS LN) Full year results in line | Futura Medical (FUM LN) Licensing deal for CSD500 in Portugal | Verona Pharma (VRP LN) Global agreement with QuintilesIMS to support development of RPL554 | Xaar (XAR LN) 2016 results slightly ahead, reduced visibility in 2017
Small Cap Breakfast
21 Mar 17
First Sentinel—Investment company expecting NEX admission/introduction on 24 March. £636k raised pre-IPO. BioPharma Credit—Expected Gross Initial Acquisition Proceeds now c.$338m. Gross Cash Proceeds capped at $423m with placing and open offer. Results expected 23 March with admission now due 30 march. Tufton Oceanic Assets- The Company intends to invest in a diversified portfolio of second hand commercial sea-going vessels where the Investment Manager believes that an attractive opportunity exists in shipping. $150m raise. Admission 3 April.